Nursing management of the patient with new variant
Creutzfeldt-Jakob Disease (nvCJD) includes
a) providing supportive care.
The nvCJD is a progressive fatal disease with no treatment available.
Due to the fatal outcome of nvCJD, nursing care is primarily
supportive.
b) initiating isolation procedures.
Prevention of disease transmission is an important part of providing
nursing care. Although patient isolation is not necessary, use of
standard precautions is important. Institutional protocols are followed
for blood and body fluid exposure and decontamination of equipment.
c) preparing for organ donation.
Organ donation is not an option because of the risk for disease
transmission.
d) administering amphotericin B.
Amphotericin B is used in the treatment of fungal encephalitis; no
treatment is available for nvCJD.
Creutzfeldt-Jakob Disease (nvCJD) includes
a) providing supportive care.
The nvCJD is a progressive fatal disease with no treatment available.
Due to the fatal outcome of nvCJD, nursing care is primarily
supportive.
b) initiating isolation procedures.
Prevention of disease transmission is an important part of providing
nursing care. Although patient isolation is not necessary, use of
standard precautions is important. Institutional protocols are followed
for blood and body fluid exposure and decontamination of equipment.
c) preparing for organ donation.
Organ donation is not an option because of the risk for disease
transmission.
d) administering amphotericin B.
Amphotericin B is used in the treatment of fungal encephalitis; no
treatment is available for nvCJD.